Table 1 Clinical Characteristics.
Healthy controls (n = 14) | Asymptomatic smokers (n = 17) | Asthma (n = 73) | p-value | |
---|---|---|---|---|
Age (years) | 50 (18) | 50 (14) | 59 (14) | 0.018 |
Sex (% male (n))b | 57 (8) | 29 (5) | 53 (39) | 0.276 |
BMI (kg/m2) | 26.2 (4.3) | 29.6 (5.9) | 30.0 (6.0) | 0.089 |
Smoking pack year history | 6 (0) | 27.6 (14) | 8.5 (8)* | 0.0003 |
GINA treatment step (number per group: 1, 2–4, 5)b | — | — | 4, 58, 11 | — |
ACQ-6 | — | — | 1.04 (1.05) | — |
AQLQ | — | — | 5.66 (1.33) | — |
FEV1 (L) | 3.47 (0.86) | 2.95 (0.80) | 2.54 (0.85)φ | 0.0007 |
FEV1 GLI score | 0.89 (1.21) | −0.02 (0.7) | −0.93 (1.27)φ,* | <0.0001 |
FVC (L) | 4.39 (0.87) | 3.65 (1.01) | 3.46 (0.87)φ | 0.003 |
FVC GLI score | 0.99 (1.40) | −0.09 (0.87) | −0.37 (1.05)¥,φ | 0.0002 |
FEV1/FVC | 0.78 (0.05) | 0.81 (0.06) | 0.71 (0.11)φ,* | 0.0003 |